Skip to main content
Log in

Expression of IRF-4 and IBP in skin lesions of patients with psoriasis vulgaris

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The expression of the interferon regulatory factor 4 (IRF-4) and the IRF-4-binding protein (IBP) in psoriatic skin lesions was investigated. The expression of IRF-4 and IBP in skin lesions of 20 patients with psoriasis vulgaris were immunohistochemically dectected. Normal skin from 10 healthy people was used as normal control. The study showed that expression of IRF-4 was increased significantly in keratinocytes and inflammatory cells in the lesions of psoriasis vulgaris than that in the normal control. The detection revealed that IBP expression in keratinocytes, lymphocytes, hair follicles, and sebaceous glands in normal skin was significantly lower than that in the lesions of psoriasis vulgaris (P<0.05). Both IRF-4 and IBP might be involved in the pathogenesis of psoriasis vulgaris.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol, 2010,10(12):849–859

    Article  PubMed  CAS  Google Scholar 

  2. Ouyang W, Kolls JK, Zheng Y, et al. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity, 2008,28(4):454–467

    Article  PubMed  CAS  Google Scholar 

  3. Di Cesare A, Di Meglio P, Nestle FO, et al. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol, 2009,129(6):1339–1350

    Article  PubMed  Google Scholar 

  4. Brüstle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol, 2007,8(9):958–966

    Article  PubMed  Google Scholar 

  5. Gupta S, Lee A, Hu C, et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Hum Immunol, 2003,64(4):389–401

    Article  PubMed  CAS  Google Scholar 

  6. Chen Q, Yang W, Gupta S, et al. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of irf-4 transcription factor. Immunity, 2008,29(6):899–911

    Article  PubMed  CAS  Google Scholar 

  7. Canonigo-Balancio AJ, Fos C, Prod’homme T, et al. SLAT/Def6 plays a critical role in the development of th17 cell-mediated experimental autoimmune encephalomyelitis. J Immunol, 2009,183(11):7259–7267

    Article  PubMed  CAS  Google Scholar 

  8. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol, 2008,128(5):1207–1211

    Article  PubMed  CAS  Google Scholar 

  9. Li J, Chen X, Liu Z, et al. Expression of Th17 cytokines in skin lesions of patients with psoriasis. Huazhong Univ Sci Technolog [Med Sci], 2007,27(3):330–332

    Article  Google Scholar 

  10. Huber M, Brüstle A, Reinhard K, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci USA, 2008,105(52):20 846–20 851

    Article  CAS  Google Scholar 

  11. Caruso R, Botti E, Sarra M, et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med, 2009,15(9):1013–1015

    Article  PubMed  CAS  Google Scholar 

  12. Shaffer AL, Emre NC, Romesser PB, et al. IRF4: Immunity. Malignancy! Therapy? Clin Cancer Res, 2009, 15(9):2954–61

    Article  PubMed  CAS  Google Scholar 

  13. Gualco G, Weiss LM, Bacchi CE. MUM1/IRF4: A review. Appl Immunohistochem Mol Morphol, 2010,18(4): 301–310

    Article  PubMed  CAS  Google Scholar 

  14. Biswas PS, Bhagat G, Pernis AB. IRF-4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol Rev, 2010,233(1):79–96

    Article  PubMed  CAS  Google Scholar 

  15. Fanzo JC, Yang W, Jang SY, et al. Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. J Clin Invest, 2006,116(3):703–714

    Article  PubMed  CAS  Google Scholar 

  16. Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol, 2008,181(4):2277–2284

    PubMed  CAS  Google Scholar 

  17. Biswas PS, Gupta S, Chang E, et al. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest, 2010,120(9):3280–3295

    Article  PubMed  CAS  Google Scholar 

  18. Nurieva RI, Dong C. Keeping autoimmunity in check: How to control a Th17 cell controller. Immunity, 2008,29(6):841–843

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jiawen Li  (李家文).

Additional information

This project was supported by grants from the National Natural Sciences Foundation of China (No. 30972654 and No. 81171495).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ni, A., Chen, H., Wu, Y. et al. Expression of IRF-4 and IBP in skin lesions of patients with psoriasis vulgaris. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 32, 287–290 (2012). https://doi.org/10.1007/s11596-012-0050-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-012-0050-6

Key words

Navigation